Business Segments · Product revenues, net
Pharmaceuticals — Product revenues, net
Vertex Pharmaceuticals Pharmaceuticals — Product revenues, net increased by 3.7% to $3.19B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.5%, from $2.91B to $3.19B. Over 3 years (FY 2022 to FY 2025), Pharmaceuticals — Product revenues, net shows an upward trend with a 10.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2022
Last reportedQ4 2025
Rolls up toTotal Revenue
How to read this metric
An increase indicates strong market adoption and successful commercialization of the drug portfolio.
Detailed definition
Represents the total revenue generated from the sale of pharmaceutical products after accounting for returns, rebates, a...
Peer comparison
Standard across all pharmaceutical companies as 'Net Product Sales'.
Metric ID:
vrtx_segment_pharmaceuticals_product_revenues_netHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.23B | $2.23B | $2.23B | $2.23B | $2.47B | $2.47B | $2.47B | $2.47B | $2.69B | $2.65B | $2.77B | $2.91B | $2.77B | $2.96B | $3.08B | $3.19B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +10.5% | +0.0% | +0.0% | +0.0% | +9.1% | -1.7% | +4.8% | +5.1% | -4.9% | +7.0% | +3.8% | +3.7% |
| YoY Change | — | — | — | — | +10.5% | +10.5% | +10.5% | +10.5% | +9.1% | +7.2% | +12.3% | +18.0% | +3.0% | +12.1% | +11.0% | +9.5% |
Range$2.23B – $3.19B
CAGR+10.0%
Avg YoY Growth+10.4%
Median YoY Growth+10.5%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's pharmaceuticals — product revenues, net?
- Vertex Pharmaceuticals (VRTX) reported pharmaceuticals — product revenues, net of $3.19B in Q4 2025.
- How has Vertex Pharmaceuticals's pharmaceuticals — product revenues, net changed year-over-year?
- Vertex Pharmaceuticals's pharmaceuticals — product revenues, net increased by 9.5% year-over-year, from $2.91B to $3.19B.
- What is the long-term trend for Vertex Pharmaceuticals's pharmaceuticals — product revenues, net?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's pharmaceuticals — product revenues, net has grown at a 10.4% compound annual growth rate (CAGR), from $8.93B to $12.00B.
- What does pharmaceuticals — product revenues, net mean?
- The total money earned from selling drugs after subtracting sales-related deductions.